Cite
HARVARD Citation
Fujita, Y. et al. (2019). ACGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer. Oncologist. pp. 327-337. [Online].